![]() Currently, patients are defined to be at low risk by age 60 and/with prior thrombosis, still exhibit an annual rate of major thrombotic episodes of 2%. The first step in approaching an individual patient with PV is to identify the potential risk to develop major thrombotic or hemorrhagic complications. ![]() Patients with PV may suffer on the short term of devastating vascular events, and on the long term of transformation of their hematologic malignancy in myelofibrosis, myelodysplastic syndrome, or acute myeloid leukemia. ![]() Polycythemia vera (PV) is a dangerous disease.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |